3. RECURRENT RELATED PARTY TRANSACTIONS During the financial period that ended 31 December 2023, the Company did not enter any recurrent related party transaction that requires the shareholders’ mandate. 4. MATERIAL CONTRACTS Save as disclosed in the Audited Financial Statements for the financial period ended 31 December 2023, there were no material contracts entered into by the Company and DNeX Group involving the interests of directors, chief executive who is not a director or major shareholders, either still subsisting at the end of the financial period ended 31 December 2023 or entered into since the end of the previous financial year. 5. CONTRACTS RELATING TO LOANS During the financial period ended 31 December 2023, there were no material contracts relating to loans entered by the Company and its subsidiaries involving the directors, chief executive who is not a director or major shareholders. 6. EMPLOYEES’ SHARE OPTION SCHEME (“ESOS”) The Company had, during its Extraordinary General Meeting held on 1 April 2021, obtained shareholders’ approval in relation to the implementation of an ESOS of up to 5% of the total number of issued shares of the Company (excluding treasury shares, if any) at any point in time over the duration of the ESOS for the eligible directors and employees of the Company and its subsidiaries (excluding dormant subsidiaries). The ESOS shall be in force for five (5) years from the implementation date of 6 April 2021, and this is the only ESOS in existence during the financial period ended 31 December 2023. During the financial period that ended 31 December 2023, a total of 76,500 new ordinary shares were issued and allotted pursuant to the exercise of the ESOS options. A brief detail on the number of ESOS options granted, exercised, forfeited and outstanding since commencement on 6 April 2021 to 31 December 2023 is set out in the tables below: For the period from 6 April 2021 to 31 December 2023 Number of Options Description Grand Total Directors and Chief Executive Granted 76,626,800 59,509,700 Exercised 1,047,750 1,047,750 Forfeited 16,846,810 12,376,600 Outstanding 58,732,240 46,085,350 Integrated Report 2023 165
RkJQdWJsaXNoZXIy NDgzMzc=